(Q42659776)

English

Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status

scientific article published on July 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multiple sclerosis

0 references

author name string

Ostberg A

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pittas F

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Taylor B

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Internal Medicine Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

382-387

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Clinical scales for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Clinical scoring methods for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

The psychometric properties of clinical rating scales used in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2005.00862.X

21 January 2018

Identifiers

10.1111/J.1445-5994.2005.00862.X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42659776&oldid=1964698837"